Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Silo Pharma (SILO) Interest & Investment Income (2016 - 2025)

Historic Interest & Investment Income for Silo Pharma (SILO) over the last 11 years, with Q3 2025 value amounting to $44604.0.

  • Silo Pharma's Interest & Investment Income fell 4748.76% to $44604.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $234355.0, marking a year-over-year decrease of 3463.61%. This contributed to the annual value of $333165.0 for FY2024, which is 1640.15% down from last year.
  • Silo Pharma's Interest & Investment Income amounted to $44604.0 in Q3 2025, which was down 4748.76% from $44917.0 recorded in Q2 2025.
  • Silo Pharma's Interest & Investment Income's 5-year high stood at $116178.0 during Q3 2023, with a 5-year trough of $377.0 in Q2 2022.
  • For the 4-year period, Silo Pharma's Interest & Investment Income averaged around $68233.3, with its median value being $73953.0 (2022).
  • In the last 5 years, Silo Pharma's Interest & Investment Income soared by 2896737.4% in 2023 and then plummeted by 4748.76% in 2025.
  • Silo Pharma's Interest & Investment Income (Quarter) stood at $70864.0 in 2022, then skyrocketed by 52.94% to $108380.0 in 2023, then fell by 23.41% to $83006.0 in 2024, then plummeted by 46.26% to $44604.0 in 2025.
  • Its Interest & Investment Income was $44604.0 in Q3 2025, compared to $44917.0 in Q2 2025 and $61828.0 in Q1 2025.